Singapore, May 9, 2008: Covance, with headquarters in Princeton, New Jersey and a comprehensive drug development services company has elected Mr Joseph C. Scodari to its Board of Directors. He has a distinguished 34-year career as a key leader in the pharmaceutical and biotechnology industries, and has a proven track record of driving growth in large, complex global healthcare businesses.

 

Mr Scodari was recently the worldwide chairman of the Johnson & Johnson Pharmaceuticals Group. In this role, he led efforts to improve research and development productivity and build a more robust pipeline. He was also a member of the J&J executive committee and a corporate officer. Before Mr Scodari was appointed worldwide chairman of J&J's pharmaceutical business in 2005, he was the company group chairman of J&J's global biopharmaceuticals business and was responsible for commercial activities in biotechnology and for specialty businesses in oncology and virology. Mr Scodari has also held leadership positions in Rhone-Poulenc Rorer Pharmaceuticals and Sterling Drug.

 

Mr Scodari recently served as the vice chairman of the board and member of the executive committee of the Biotechnology Industry Organization (BIO). He has also served on the Board of Overseers of the Robert Wood Johnson School of Medicine and on the Board of Trustees of The University of the Sciences in Philadelphia. He was also previously a member of the Board of Directors of Pharmacyclics, a biopharmaceutical company focused on therapies for cancer. He has a B.A. from Youngstown State University.